Join our Waitlist for Expert Advice!

The Challenges of Two Spanish Women Founders Who are Competing with Elon Musk Both are part of a new crop of BCI European initiatives targeting brain disorders working at the intersection of deeptech, medtech, and digital health.

By Novobrief

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur Europe, an international franchise of Entrepreneur Media.

Andriy Onufriyenko | Getty Images

Brain-Computer Interface (BCI) startups have been developing over the past years, with Elon Musk's Neuralink emerging as the most visible in the sector. Aside from appearing in the news all the time, Musk is not leading the way in BCI. Rather, he is overshadowing other initiatives by overpromising results and doing so loudly from his privileged media spotlight. With human trials on the way, the race for developing brain implants will intensify this year.

Within the same sector and with less fanfare, two women-led Barcelona-based startups are getting closer to treating diseases like Alzheimer's, Parkinson's, epilepsy, and depression. Inbrain, led by Carolina Aguilar, and Neuroelectrics, led by Ana Maiques, are on a quest for more trials, more financing, and more visibility as women in deeptech/medtech.

As Aguilar mentioned last year, "What Elon Musk is doing from the awareness perspective is in some ways good, but in other ways not that good because it's kind of spoiling the good science behind it and making it a show." In 2021 Maiques also said, "I was literally told by a venture capitalist: "Put in a man to raise money for you'".

It's clear that the relationship between media coverage and production is unfairly inverted, with one billionaire taking up a lot of space. Women leaders such as Aguilar and Maiques, who have a history of successful scientific advances, can contribute to a much-needed discussion of being a woman in deeptech/medtech.

With that being said, what are the challenges of being both a female founder in deeptech/medtech and being in the same sector as Elon Musk?

Debunking myths

This story reflects on the role of VC, the media, building myths, and the challenges that women founders are still experiencing when it comes to raising money. Data shows that only 15% of innovative startups are founded or co-founded by women (and they have a harder time raising money). It's already challenging being a women entrepreneur, but the two-fold challenge of being a minority and competing with a superstar raises the bar even higher.

When we talk about Inbrain and Neuroelectrics we are talking about highly innovative ideas with practical solutions regarding brain health and treatments for diseases like Parkinson's, Alzheimer's, epilepsy, and depression.

The most interesting thing about Inbrain is its patented graphene technology. There are many uses for graphene in different industries. The most recent research is showing the capabilities of graphene-based technology to detect signs of epilepsy. Inbrain has spent almost a decade developing a patented manufacturing process that makes graphene stable for many years to be used in brain implants. Graphene doesn't degrade after millions of pulses of stimulation. "Brain interfaces need to do three things well: record brain signals, stimulate them and then be stable for many, many years in the brain," Inbrain cofounder and chief executive Carolina Aguilar has said.

Neuroelectrics, on the other hand, is all about brain stimulation and monitoring with their own patented helmet. Neuroelectrics was greenlighted by the FDA last year to conduct clinical trials of brain stimulation therapy with telemedicine for patients with Major Depressive Depression (MDD). Also granted was the FDA Breakthrough Device Designation for new therapeutic Neuromodulation platform to treat refractory focal epilepsy. According to Maiques, CEO of Neuroelectrics, advances in the use of therapies involving light, sound, and electrical impulses are all going to make headlines in 2022, providing further proof and evidence for non-invasive, non-chemical interventions in brain disease.

These two startups are in the intersection of deeptech, medtech and digital health, which are also spin-offs of public and private institutions. They are a part of a new crop of BCI European initiatives targeting brain disorders. We will soon see their tech becoming more mainstream to treat patients with these diseases. Graphen implants and brain stimulation will become the norm thanks to these startups. That is if Elon Musk can make space for more people in the room.

Novobrief is an English language news publication covering the Spanish startup ecosystem. 
Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Business News

Meta Fires Employee Making $400,000 Per Year Over a $25 Meal Voucher Issue

Other staff members were fired for the same reason, per a new report.

Business News

5 Common Mistakes Made in Amazon Product Listings and How to Fix Them

Sloppy mistakes in your sales listings equal low sales on Amazon. Find out what you can do to polish your product listings.

Thought Leaders

These 3 Trends Will Change What It Means to Be an Entrepreneur in 2025

Here are three entrepreneurship trends from the new Global Entrepreneurship Monitor report that are changing the landscape for the future.

Side Hustle

I Made $14,000 in 1 Week With a Spontaneous Halloween Costume Side Hustle — Here's How

Sabba Keynejad was in art school when he started to refine his entrepreneurial skills.

Business News

Mark Zuckerberg Does a Better Job Than His Rivals at Explaining AI — And It's Helping Meta Outperform Alphabet, Amazon and Microsoft

Meta has been using AI for content recommendations, keeping users' attention for longer periods of time.